Chemomab Therapeutics Ltd. (CMMB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Chemomab Therapeutics Ltd...

    NASDAQ: CMMB · Real-Time Price · USD
    2.57
    -0.03 (-1.15%)
    At close: Sep 25, 2025, 10:15 AM

    Chemomab Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 53.25K 66.83K 57.77K 34.02K
    Gross Profit
    		 -53.25K -66.83K -57.77K -34.02K
    Operating Income
    		 -14.74M -25.46M -28.53M -12.37M
    Interest Income
    		 797.77K 1.24M 351.62K 65.00
    Pretax Income
    		 -13.95M -24.22M -28.18M -12.48M
    Net Income
    		 -13.95M -24.22M -27.65M -12.48M
    Selling & General & Admin
    		 3.41K 7.08M 11.56M 6.03M
    Research & Development
    		 11.33K 18.38M 16.98M 6.33M
    Other Expenses
    		 14.72M n/a n/a n/a
    Operating Expenses
    		 14.74M 25.46M 28.53M 12.37M
    Interest Expense
    		 n/a n/a 353K 111.08K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 14.74M 25.46M 28.53M 12.37M
    Income Tax Expense
    		 n/a n/a -534K 77K
    Shares Outstanding (Basic)
    		 17.95M 11.75M 11.38M 10.37M
    Shares Outstanding (Diluted)
    		 17.95M 11.75M 11.38M 10.37M
    EPS (Basic)
    		 -0.78 -2.06 -2.42 -1.2
    EPS (Diluted)
    		 -0.78 -2.06 -2.42 -1.2
    EBITDA
    		 -13.96M -25.39M -28.48M -12.33M
    EBIT
    		 -14.01M -25.46M -28.53M -12.37M
    Depreciation & Amortization
    		 53.25K 67K 57.77K 34.02K

    Add to Watchlist